Top 50 Most Viewed Posts This Week |
Today This Week Last Week This Month Last Month
|
1. mightycydy: CYDY's Dr. Scott Hansen & The Gates Foundation (1937) (16) |
2. Rosner: Short Interest Report As of Sat, Aug 3, '13 (1624) |
3. My69z: No longer thinking my "$50b" napkin is just an (985) (6) |
4. hoops: "As previously announced, CytoDyn is preparing a (762) (17) |
5. PSU77: You're right, the quest to turn "cold" tumors (693) (32) |
6. jeff67: This drug, even though not getting through the (660) (11) |
7. ScottyDoggs: Someone on Stockwits reported that Zacks is (656) (10) |
8. Mr3Putt: So I’ll stand by my previous position that you (645) (24) |
9. Ramjet: Right on Onward and upward To approval and beyond (643) (2) |
10. sjacobs26: Patients, shareholders, and our future partner/s (641) (14) |
11. misiu143: I agree with you Jeff . Treating so many diseases (621) (20) |
12. ScottyDoggs: The data exceeds my most optimistic expectations (614) (15) |
13. biloxiblues: This could explain a lot of the selling over the (613) (21) |
14. KenChowder: My takeaway from the PR is this, and it is no (611) (26) |
15. ohm20: My takeaway from the PR is this, and it is no (607) (21) |
16. Jake2212: Nobody is mentioning that the quotes from Jay and (602) (19) |
17. mountaineer: Yes, it is totally speculation (but something we (599) (8) |
18. grow: IMO the pooled safety data to me means there is (598) (7) |
19. Mr3Putt: Definitely check out this post at reddit: (592) (11) |
20. Katangolo: It doesn’t escape me that ESMO and this breast (584) (31) |
21. biloxiblues: This is probably the best question ever asked on (581) (15) |
22. Respert24: Let's not forget that many of these patients went (581) (21) |
23. misiu143: There were 3 preclinical studies done recently (580) (15) |
24. MidnightRider: We all speculated as to why the Dream Team all (573) (8) |
25. Riztheinvestor: He’s blanket deleted. I can’t take his (572) (13) |
26. Boatbuilder: Today will be interesting. Frequently when the (566) (8) |
27. My69z: Trump EO on drug pricing out: (560) (6) |
28. Plotinus: Beyond the PR today: inferences of note: Outside (560) (31) |
29. ohm20: I just saw the presentation poster. High PD-L1 (556) (35) |
30. ohm20: PD-L1 is a defense mechanism by the tumor. PD-L1 (556) (29) |
31. Riztheinvestor: It means anyone with PD-L1s will be knocking on (556) (15) |
32. Ganesha: Re Zack’s: Well, it couldn’t hurt! Maybe (555) (4) |
33. KenChowder: Forgot to add this: "CytoDyn’s results indicate (553) (26) |
34. biloxiblues: 3rd Resistance Point 0.4969 2nd Resistance Point (553) (4) |
35. Katangolo: I want to be clear Craig. I’m not your friend. (550) (19) |
36. biloxiblues: This ESMO 2025 poster from CytoDyn presents (549) (12) |
37. Katangolo: Thanks, Riz. I hope you and the other mods delete (549) (17) |
38. mountaineer: Big picture: It is STILL a big (542) (5) |
39. chazzledazzle: “ Mr. Vittner on our CRC protocol…” Is (541) (1) |
40. mountaineer: I do not believe they would make an announcement (536) (5) |
41. Crujones1985: Anyone have access from the ground in (536) (1) |
42. Mrkev: I am completely baffled as to how maraviroc is (535) (10) |
43. hoops: The fact that Cytodyn’s leadership team flew (534) (9) |
44. PSU77: Finally some media coverage: (533) (17) |
45. KenChowder: Of all the flags pointing in the right (533) (16) |
46. mfglola: I am completely baffled as to how maraviroc is (533) (3) |
47. hoops: Apparently "Oncodaily" is reporting from ESMO. I (533) (1) |
48. ohm20: Question: Are you satisfied with our current (532) (15) |
49. Buddyboy20: Does anybody remember this? "The fact that (531) (16) |
50. mikeyt1818: Let's hope the IR Med S-1 means they are getting (530) (7) |